Indutrade is an international technology and industrial business group that manufactures, markets, and sells high-tech components, systems, and services to selected industrial niches. The group operates through two main business areas: Industrial & Engineering and Technology & Systems Solutions. Its product portfolio includes measurement technology, valves, industrial equipment, medical technology, pipes and pipe systems, construction materials, fasteners, electronics, industrial springs, chemical technology, filters and process technology, pumps, and automation. Indutrade serves customers in sectors such as medical technology and pharmaceuticals, infrastructure and construction, engineering, energy, water and wastewater, process industry, commercial vehicles, marine, food, mining, steel, automotive aftermarket, and pulp and paper. The company operates in Sweden, the UK and Ireland, Benelux, Denmark, Finland, Norway, Germany, Switzerland, Austria, North America, Asia, and Eastern Europe. Founded in 1978 and renamed Indutrade in 1989, the group grew through the acquisition of numerous companies, including recent acquisitions such as ATM Group and Magistor. The company is listed on the stock exchange since 2005.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Conglomerates Homepage indutrade.com
Sector Industrials IR page indutrade.com
Tags
industrial components, measurement technology, valves, medical technology, process technology, industrial equipment, fasteners, pumps, automation, chemical technology, pipe systems, construction materials, ATM Group, Magistor, Hanwel Europe B.V, Satron, Saniflex, Puwimex, Kontram, Fagerberg, GEFA, EIE, Tecalemit, Pentronic, Alnab, Hitma, Bloch & Andresen, Colly Group, Bengtssons Maskin, Carlsson & Möller, Flintec Group, Key Valve Technologies, Abima Group, Dacke Komponent, AB Nils Dacke, Wilhelm Sonesson AB
Press page indutrade.com/investors--media/press-releases/press-release

Metrics

Valuation  
Market cap kr 92.392B
Market cap (USD) $ 9.139B
P/E 32.84
PEG —
P/BV 5.33
P/S 2.87
P/OCF 23.16
P/FCF —
Dividend yield —
Turnover / mcap —
Returns  
ROE 15.2%
ROI 10.9%
ROIC 12.3%
Profit margin 7.9%
Growth  
Revenue growing No
Profits growing No
Revenue up 3y No
Revenue up 5y —
Earnings growth 3y (net profit CAGR) -1.5%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 37.6%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 22
Quality score 0%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Revenue 32.229B 32.544B 31.835B 27.016B 21.715B — 18.411B 16.848B 14.847B 12.955B 11.881B 9.746B 8.831B 8.384B 7.994B 6.745B 6.271B
Net profit 2.562B 2.75B 2.866B 2.681B 2.097B — 1.482B 1.367B 1.029B 936M 893M 704M 587M 565M 540M 407M 341M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009
Share price 200 282.76 231.92 203.11 214.89 499.22 — 215.88 172.65 172.65 — — — — — — —
Price performance 12m -0.29 0.22 0.14 -0.05 -0.57 — — 0.25 0 — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (SEK) — 2.93B 3.46B 4.45B 4.41B 4.76B 4.75B
↳ YoY growth +18.2% +28.7% -0.9% +7.9% -0.3%
↳ 5y CAGR +10.2%
Other receivables (SEK) — 304M 292M 343M 415M 434M 437M
Cash and deposits (SEK) 719M 758M 1.46B 1.59B 3.01B 3.05B 2.39B
Right-of-use assets (SEK) — 1.04B 1.06B 1.23B 1.44B 1.58B 1.48B
Cash flow detail
Operating cash flow (SEK) — 2.78B 2.85B 2.37B 4.49B 4.13B 3.99B
Purchases of property, plant and equipment (SEK) — -390M -339M -511M -519M -485M -502M
Purchases of intangible assets (SEK) — -37M -35M -36M -41M -36M -42M
Change in receivables (cash effect) (SEK) — 35M -149M -611M 190M -40M -38M
Change in inventories (cash effect) (SEK) — 66M -374M -1.01B 417M 283M 257M
Change in payables (cash effect) (SEK) — -58M 288M 98M -183M 73M -166M
Dividends paid (cash effect) (SEK) — — -655M -837M -946M -1.04B -1.09B
Interest paid (cash effect) (SEK) — -92M -84M -160M -421M -519M -447M
Income taxes paid (cash effect) (SEK) — -508M -638M -764M -1.05B -1.13B -1.1B
Share-based compensation (SEK) — — -13M — — — —
Operating cash flow before change in receivables (SEK) — 2.75B 3B 2.98B 4.3B 4.17B 4.03B
Free cash flow (OCF - PPE - intangibles) (SEK) — 2.35B 2.48B 1.83B 3.93B 3.61B 3.45B
Income detail
Research and development expense (SEK) — 227M 258M 334M 395M 406M 378M
↳ 5y CAGR +10.7%
Total comprehensive income (SEK) — 1.38B 2.34B 3.31B 2.67B 3.2B 1.58B
Comprehensive income to owners (SEK) — 1.38B 2.34B 3.31B 2.67B 3.2B 1.58B
Reported — — — — — — —

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

Interim report 1 January – 30 September 2026 Bull 4 Bear 0 Results

2026-10-23

Strong profitable growth

Third quarter 2026

  • Order intake increased by 16% and amounted to SEK 8,991 million (7,735). For comparable units, the increase was 6%.
  • Net sales increased by 13% and amounted to SEK 8,871 million (7,846). For comparable units, the increase was 5%.
  • EBITA increased by 19% to SEK 1,358 million (1,143), corresponding to an EBITA margin of 15.3% (14.6%).
  • Profit for the quarter increased by 19% to SEK 804 million (674) and earnings per share amounted to SEK 2.21 (1.85).
  • Cash flow from operating activities amounted to SEK 1,216 million (1,016).

CEO’s message

Third quarter
Demand continued to improve in the third quarter. Order intake amounted to SEK 9.0 billion (7.7), an increase of 16%, of which 6% was organic. Development was positive in all business areas and the majority of the companies. The increase was largest in companies with customers in medical technology and pharmaceuticals, energy and engineering. The book-to-bill ratio was positive, thus further strengthening the order backlog.

Net sales increased 13% to SEK 8.9 billion (7.8), with acquisitions contributing 8% and organic growth 5%. All business areas grew organically, with Process, Energy & Water seeing the strongest development. In Process, Energy & Water, deliveries increased due to the strong order backlog built up in recent quarters, primarily in the energy segment. In Life Science and Industrial & Engineering, the majority of companies developed positively. Development was positive also in Infrastructure & Construction and Technology & Systems Solutions, although from slightly lower levels.

EBITA increased 19% to SEK 1.4 billion (1.1), corresponding to an EBITA margin of 15.3% (14.6%). The margin improvement was mainly driven by the strong organic sales growth, as well as positive effects from acquisitions. Thanks to successful pricing efforts, the gross margin remained at a stable high level. The EBITA margin improved in three out of the five business areas compared with the corresponding period in the previous year, with Industrial & Engineering showing the strongest development.

Cash flow from operating activities improved and amounted to SEK 1.2 billion (1.0), due primarily to the strong earnings. Despite the good acquisition pace, the debt/equity ratio is low and the Group’s financial position remains very strong.

Acquisitions
To date this year, we have acquired or signed agreements to acquire 13 companies with combined annual sales totalling SEK 2.1 billion. Acquisition effects on net sales and EBITA increased and amounted to 8% and 10% respectively. Since the end of the quarter, we have announced the acquisition of two life science companies, Euromed and Sinmed, which will strengthen our presence in Poland, as well as Schraner, a German company specialising in fire protection systems.

The inflow of acquisition candidates remains high, and our business areas are working to generate more acquisition candidates through the internal network. Our financial position is strong, laying a firm foundation for a continued good acquisition pace moving forward.

Outlook
The strong order backlog and continued high acquisition pace lay a good foundation for upcoming quarters. Some of the growth in order backlog is driven by the major investments in energy being made across Europe, projects that generally have long lead times. There is however remaining uncertainty in the general economy, mainly linked to the geopolitical situation.

Several of our companies are well positioned in structurally growing markets, and our decentralised model provides a solid platform for continued, sustainable profitable growth.

Bo Annvik, President and CEO

2026-10-23

Indutrade has signed an agreement to acquire all shares in the German company Schraner GmbH, **www.schraner.de **, with annual sales of approximately EUR 8 million (SEK 90 million).

Schraner is a specialised manufacturer of fire peripheral solutions and sensors, mainly for the German market. The product offering includes boards and control units for fire brigade access, complemented by fire detection products and signalling devices from leading suppliers. The company has a diverse customer base, including industrial OEMs and installation companies.

Schraner was founded in 1994, has 35 employees and is located in Erlangen, Germany. The company has a strong position in its niche, high technical expertise and good prerequisites for continued sustainable, profitable growth.

Closing took place on 22 October and Schraner will be included in Indutrade's Business Area Infrastructure & Construction. The acquisition is Indutrade's 13th in 2026 and is expected to have a marginally positive impact on Indutrade's earnings per share.

2026-10-21

Indutrade has signed an agreement to acquire all shares in the Polish company Sinmed Sp. z o.o, **www.sinmed.pl/en **, with annual sales of approximately PLN 50 million (SEK 130 million).

Sinmed is a technical trading company specialised in single-use products and medical consumables. The product offering includes products for anaesthesiology and patient hygiene, as well as positioners and fixation products. The company has a diverse customer base, including hospitals, universities, healthcare providers and medical technology distribution companies.

Sinmed was founded in 2016, has 48 employees and is located in Przyszowice, Poland. The company has a strong position in its niche, long-term partnerships and good prerequisites for continued sustainable, profitable growth.

Closing is conditional upon approval by the Polish competition authority and is expected to be finalised during Q4 2026. Sinmed will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's twelfth in 2026 and is expected to have a marginally positive impact on Indutrade's earnings per share.

Prompts

Indutrade (ticker INDT), listed in Sweden.

ETFs Holding Indutrade

ETF Weight in ETF Shares Market value As of
FFDI 0.66% 5,120 $ 128.401K Jul 31, 2026
FFGX 0.56% 12,050 $ 302.193K Jul 31, 2026
AVDE 0.03% 244,037 $ 6.393M Nov 16, 2026
AVSD 0.03% 4,508 $ 118.095K Nov 16, 2026
JSTC 0.03% 3,160 $ 83.253K Nov 17, 2026
DFSI 0.02% 11,088 $ 294.413K Nov 12, 2026
DFAI 0.02% 146,764 $ 3.897M Nov 12, 2026
DFIC 0.02% 103,136 $ 2.739M Nov 12, 2026
DFAX 0.01% 55,880 $ 1.484M Nov 12, 2026
DIHP 0.00% 10,979 $ 291.519K Nov 12, 2026
DXIV 0.00% 239 $ 6,346.02 Nov 12, 2026